MagneCit is a supplemental nutritional product that contains magnesium citrate and vitamin B6. The main benefits of these two ingredients are:

  • Magnesium citrate anhydrate displays highest solubility among the organic magnesium salts.1, 2
  • Vitamin B6 increases the active transport of magnesium across cell membranes.3
  • Vitamin B6 depletion increases magnesium urinary excretion.4


The dosage of MagneCit for adults is 1–2 tablets daily. The daily dosage contains:

  • Magnesium 150–300 mg (40–80 %*)
  • Vitamin B6 (pyridoxine) 1,5–3 mg (107–214 %*)

* Percent of recommended daily intake

Do not exceed the recommended daily dose. Food supplements do not replace a balanced diet and healthy life-style.


Packing sizes

  • 30 coated tablets (blister)
  • 60 coated tablets
  • 100 coated tablets
  • 200 coated tablets
  • 100 chewable tablets


MagneCit film coated tablet: Magnesium citrate (anhydrate), fillers (micro­crystalline cellulose, hydroxy­propyl methyl­cellulose), anti­caking agents (magnesium salts of fatty acids, silicon dioxide), film coating (hydroxy­propyl methyl­cellulose, talc, titanium dioxide, poly­ethylene glycol), disintegrant (sodium carboxy­methyl starch), pyridoxine hydro­chloride (vitamin B6).

One tablet contains 950 mg magnesium citrate anhydrate responding 150 mg elemental magnesium.

MagneCit film coated tablets do not contain lactose, yeast, gluten or sweeteners.

MagneCit chewable tablet: Magnesium citrate (nonahydrate and anhydrate), sweeteners (sorbitol, xylitol, steviol glycosides), anti­caking agent (magnesium salts of fatty acids), orange aroma, acidity regulator (citric acid), pyridoxine hydro­chloride (vitamin B6).

MagneCit chewable tablets do not contain lactose, yeast or gluten. MagneCit chewable tablets contain sweeteners; excess consumption may have a laxative effect.


  1. Walker AF, et al. Magnes Res 2003;16:183–191
  2. Gernster G. Agrofood Industry Hi-tech 2006;17
  3. Abraham G, et al. Ann Clin Lab Sci 1981;11:333–336
  4. Turnlund JR, et al. Am J Clin Nutr 1992;56:905–910